Kevin Hourican Sysco Corp (SYY) insider trading activity

Kevin Hourican is Chair and CEO of SYSCO CORP. Currently has a direct ownership of 409,186 shares of SYY, which is worth approximately $30.1 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 6,811 shares (Common Stock) at a price of $77.97 per share, resulting in proceeds of $531,053. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 409K

1.64% 3M change

20.18% 12M change

Total Value Held $30.1 Million

Kevin Hourican Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Payment of exercise price or tax liability	$531,053 $77.97 p/Share	6,811 Reduced 1.64%	409,186 Common Stock
Aug 21 2024	BUY Grant, award, or other acquisition	-	49,420 Added 10.62%	415,997 Common Stock
Aug 12 2024	SELL Payment of exercise price or tax liability	$477,149 $75.63 p/Share	6,309 Reduced 1.69%	366,577 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$1,607,074 $76.44 p/Share	21,024 Reduced 5.34%	372,886 Common Stock
Aug 01 2024	BUY Grant, award, or other acquisition	$4,083,883 $76.44 p/Share	53,426 Added 11.94%	393,910 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$783,910 $69.65 p/Share	11,255 Reduced 3.2%	340,483 Common Stock
Aug 10 2023	BUY Grant, award, or other acquisition	-	48,096 Added 12.03%	351,738 Common Stock
Oct 24 2022	SELL Open market or private sale	$6,093,043 $81.22 p/Share	75,019 Reduced 19.81%	303,642 Common Stock
Oct 24 2022	BUY Exercise of conversion of derivative security	$4,357,104 $58.08 p/Share	75,019 Added 16.54%	378,661 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$645,427 $82.22 p/Share	7,850 Reduced 2.52%	303,642 Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	25,961 Added 7.69%	311,492 Common Stock
Jul 29 2022	SELL Payment of exercise price or tax liability	$11,159,010 $87.28 p/Share	127,853 Reduced 30.93%	285,531 Common Stock
Jul 29 2022	BUY Grant, award, or other acquisition	-	324,907 Added 47.45%	359,869 Common Stock
Apr 08 2022	SELL Open market or private sale	$6,451,548 $86.0 p/Share	75,018 Reduced 45.88%	88,477 Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	$4,357,046 $58.08 p/Share	75,018 Added 31.45%	163,495 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$353,965 $79.65 p/Share	4,444 Reduced 4.78%	88,477 Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	25,960 Added 21.84%	92,921 Common Stock
Aug 02 2021	SELL Payment of exercise price or tax liability	$797,056 $74.2 p/Share	10,742 Reduced 13.82%	66,961 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$769,948 $71.51 p/Share	10,767 Reduced 12.17%	77,703 Common Stock

Also insider at

CVS

CVS HEALTH Corp Healthcare

EVP & President, CVS Pharmacy

TPR

TAPESTRY, INC. Consumer Cyclical

Director

Kevin Hourican

Chair and CEO

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYY shares.

Notify only if

Value

Insider Trading

Get notified when an Sysco Corp insider buys or sells SYY shares.

Notify only if

Operation

Value

Type

News

Receive news related to SYSCO CORP

Track Activities on SYY

Account